HPR 19(3): Infectious Diseases Impacting England; quarterly STI, CPO, MMR and IMD reports; travel-related infections: EWNI; updated C. auris guidance

Dear Subscriber, Welcome to the latest edition of the Health Protection Report. For quick access to any item, click on the links below to view the website content. HPR is a national public health bulletin for England and Wales, published by the UK Health Security Agency. Current news Increase in Candidozyma auris reports in England, linked to hospital outbreaks Travel-associated infections in England, Wales and Northern Ireland: 2024 Pathogen prioritisation: UKHSA guidance for industrial/academic research First annual report on infectious diseases impacting England Infection reports: STIs and blood-borne viruses Quarterly report on diagnoses of syphilis, gonorrhoea and ceftriaxone-resistant gonorrhoea in England: provisional data, March 2025 Rates of pelvic inflammatory disease (PID) diagnoses in England (2014 to 2023): an outcome of STIs and other factors Infection reports: HCAI and AMR Group A streptococcal infections: second update on seasonal activity in England, 2024/25 Carbapenemase-producing Gram-negative organisms in England since October 2020: quarterly update, Q4 2024 Point prevalence survey on HCAI, antimicrobial use and antimicrobial stewardship: England 2023 Infection reports: vaccine preventable diseases Laboratory confirmed cases of measles, mumps and rubella, England: October to December 2024 Laboratory confirmed cases of invasive meningococcal infection in England: July to September 2024 Vaccine coverage RSV maternal vaccination coverage in England: September 2024 RSV vaccine coverage report in older adults for catch-up cohorts in England: December 2024 Quarterly vaccination coverage statistics for children aged up to 5 years in the UK (COVER programme): October to December 2024 Pneumococcal polysaccharide vaccine (PPV) coverage: April 2023 to March 2024 New/updated guidance Guidance for the laboratory investigation, management, and infection prevention and control of Candidozyma auris (formerly Candida auris) Priority pathogen families research and development (R&D) tool       Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by UK Health Security Agency. This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: UK Health Security Agency (UKHSA), Nobel House, 17 Smith Square, London SW1P 3HX 020 7654 8000